“Research on the Motivation and Countermeasures of Financial Fraud of Listed Companies—Taking Kangmei Pharmaceutical as an Example” (2025) Financial Strategy and Management Reviews, 1(2), pp. 1–10. doi:10.71204/y2gzjp13.